Chronic Non-malignant Pain Clinical Trial
— PPACTOfficial title:
Collaborative Care for Chronic Pain in Primary Care
Verified date | April 2022 |
Source | Kaiser Permanente |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The overall aim of this study is to adopt an integrative rehabilitation approach for helping patients adopt self-management skills for managing chronic pain, limiting use of opioid medications, and identifying exacerbating factors amenable to treatment (e.g., depression, sleep problems) that is feasible and sustainable within the primary care setting.
Status | Completed |
Enrollment | 850 |
Est. completion date | February 2018 |
Est. primary completion date | February 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Patient inclusion criteria are: 1. Adult (18 years of age or older) Kaiser Permanente (KP) health plan members from the KP Northwest, KP Georgia, and KP Hawaii regions who receive their primary care services from participating primary care providers 2. Kaiser Permanente health plan membership of at least 180 days duration 3. Long term opioid use defined by: 90+ day supply of short acting opioid spanning at least 120 days or 2 or more long acting opioid dispense in the past 180 days 4. Pain diagnosis within the past year (based on ICD-9 or ICD-10 diagnostic codes) 5. English speaking Patient exclusion criteria are: 1. Currently enrolled in intensive addiction medicine services or evidence of active substance dependence 2. Cognitive impairment severe enough to preclude patient's participation in a behavioral/lifestyle change program 3. Current malignant cancer diagnosis 4. Having received hospice or other end-of-life palliative care within past year |
Country | Name | City | State |
---|---|---|---|
United States | Kaiser Permanente Center for Health Research | Atlanta | Georgia |
United States | Kaiser Permanente Center for Health Research | Honolulu | Hawaii |
United States | Kaiser Permanente Center for Health Research | Portland | Oregon |
Lead Sponsor | Collaborator |
---|---|
Kaiser Permanente | Duke University, National Institute of Neurological Disorders and Stroke (NINDS), Oregon Health and Science University |
United States,
DeBar L, Mayhew M, Benes L, Bonifay A, Deyo RA, Elder CR, Keefe FJ, Leo MC, McMullen C, Owen-Smith A, Smith DH, Trinacty CM, Vollmer WM. A Primary Care-Based Cognitive Behavioral Therapy Intervention for Long-Term Opioid Users With Chronic Pain : A Random — View Citation
Smith DH, O'Keeffe-Rosetti M, Leo MC, Mayhew M, Benes L, Bonifay A, Deyo RA, Elder CR, Keefe FJ, McMullen C, Owen-Smith A, Trinacty CM, Vollmer WM, DeBar L. Economic Evaluation: A Randomized Pragmatic Trial of a Primary Care-based Cognitive Behavioral Int — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain Impact Assessed Using the 4-Item Version of Brief Pain Inventory-Short Form ("PEGS") | Reliable and valid tool that measures patients' pain intensity and functional interference. The primary outcome of pain impact is assessed with the 4-item PEGS scale, a composite of pain intensity, and interference with enjoyment of life, general activity, and sleep (range, 0-10, higher score = worse pain impact). | Collected every 3 months for 1 year | |
Secondary | Pain-related Disability | Pain-related disability will be assessed using the 24-item Roland Morris Disability Questionnaire (range, 0-1, higher score = worse function) | Collected every 3 months for 1 year | |
Secondary | Average Daily Dose of Opioids | Average daily dose of opioids per 3-month quarter measured in morphine milligram equivalents (MME) | Collected every 3 months for 1 year | |
Secondary | Patient Satisfaction | Patient satisfaction with health care services will be assessed using two distinct items:
[Satisfaction with primary care services]: In the past 3 months, how satisfied have you been with your primary care services? (1, Very dissatisfied; 2, Mildly dissatisfied; 3, Indifferent; 4, Mostly satisfied; 5, Very satisfied) [Satisfaction with pain services]: In the past 3 months, how satisfied have you been with the pain services you have received? (1, Very dissatisfied; 2, Mildly dissatisfied; 3, Indifferent; 4, Mostly satisfied; 5, Very satisfied) Each item is scored individually; (range=1-5, higher score = greater satisfaction) |
Collected at baseline and 6 months (post-treatment) | |
Secondary | Health Care Costs | Costs were measured based on patient utilization of health care services and all prescription/medication costs. The costs of health care encounters during the 1-year follow-up were estimated using the standardized relative resource cost algorithm (SRRCA).
Pain-related health care costs were based on the pain-related health care encounters identified using diagnostic and procedure coding. |
Collected for 1 year post-randomization | |
Secondary | Count of Health Care Encounters by Type (Health Care Utilization) | Total Ambulatory Encounters includes encounters in the following health care service categories: Primary care; Physical therapy; Pain clinic; Other specialty medical care; Mental health; Complementary and alternative medicine; ED, urgent care, and observation beds; Hospital ambulatory visits; Same day surgeries; and Home health.
Total Pain-Related Ambulatory Encounters are a subset of Total Ambulatory Encounters and were identified using CPT, HCPCS, and ICD-9-PCS or ICD-10-PCS codes |
Collected for 1 year post-randomization | |
Secondary | Inpatient Hospital Days (Health Care Utilization) | Inpatient hospital days is the average number of days that patients stayed in hospital (total number of days spent by inpatients during the 1 year post-randomization divided by the total number of inpatient admissions) | Collected for 1 year post-randomization | |
Secondary | Total Pharmacy Dispenses (Health Care Utilization) | Total Pharmacy Dispenses is a count of the unique medication prescriptions dispensed. | Collected for 1 year post-randomization |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01888146 -
Pain Program for Active Coping & Training
|
N/A | |
Completed |
NCT00312195 -
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain
|
Phase 3 | |
Terminated |
NCT00365898 -
Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain
|
Phase 3 | |
Completed |
NCT03761277 -
Embrace TDD: Post-Market Study to Evaluate Intrathecal Morphine as an Alternative to Systemic Opioids for Chronic Pain
|
Phase 4 |